Miguel Ángel García-Aroca
Research Subjects
Miguel Ángel García-Aroca has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Adolfo Alonso-Arroyo
Department of History of Science and Documentation, University of Valencia, Valencia, Spain
2 shared publicationsAndrés López-García
Department of Anesthesiology and Reanimation, University Hospital “Madrid Montepríncipe”, Madrid, Spain
2 shared publicationsFrancisco Anguita-Rodríguez
Historical Sample of the Netherlands, Internationaal Instituut boot Sociale Geschiedenis, Amsterdam, the Netherlands
2 shared publicationsJosé Ignacio Granda-Orive
University Hospital “12 de Octubre”, Madrid, Spain, Department of Respiratory Medicine, Complutense University, Madrid, Spain
2 shared publications- Ricardo Navarro Suay
Servicio de Anestesiología y Reanimación, Hospital Universitario Central de la Defensa "Gómez Ulla", Madrid, Spain
2 shared publications - Andrés Pandiella Dominique
Universidad Carlos III de Madrid, Madrid, España
1 shared publication
Latest Publications
- Open Access
- 19 June 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (12) , 4526-4532
Development of a practice-based score to predict extended duration of proton beam therapy session in pediatric patients
Purpose: Due to the labor intensity demanded by proton beam therapy (PBT) in pediatric patients, information on operational procedures related to efficiency is crucial to optimize quality and safety. We aimed to identify patient factors that affect the duration of the pediatric PBT session and to develop an easy-to-use predictive score of extended duration. Methods/patients: This is an observational retrospective cohort study in an academic medical centre, between May 2020 and February 2024. Seventy seven ASA III pediatric patients treated with PBT were recruited. Results: The mean age was 4.8 years [standard deviation (SD): 2.1] and 52% were women. The mean duration of the PBT session was 50 min (SD: 17). Extended duration of the PBT session (> 45 min) occurred in 39 patients (51%). Five predictors of extended duration were selected for the final prediction model. In the multivariable model, an age > 45 months showed a near eightfold increased odds of extended duration [Odds ratio (OR): 7.76, 95% confidence interval (95% CI) 1.63–36.99, P = 0.010]. The OR (95% CI) for long-term venous access, no recurrent tumors, hydrocephalus, and craniospinal location were 5.91 (1.47 to 23.79), 3.81 (0.67 to 21.69), 3.79 (0.90 to 15.97), and 2.59 (0.69 to 9.76), respectively. This five-variable model was used to build a nomogram-based score with an area under the receiver operating characteristic curve of 0.84 (95% CI 0.76–0.93). Conclusions: A simple nomogram based on readily available pretreatment data has potential for planning pediatric PBT standard clinical expert practice.
- 19 June 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (12) , 4526-4532
Open AccessDevelopment of a practice-based score to predict extended duration of proton beam therapy session in pediatric patients
Purpose: Due to the labor intensity demanded by proton beam therapy (PBT) in pediatric patients, information on operational procedures related to efficiency is crucial to optimize quality and safety. We aimed to identify patient factors that affect the duration of the pediatric PBT session and to develop an easy-to-use predictive score of extended duration. Methods/patients: This is an observational retrospective cohort study in an academic medical centre, between May 2020 and February 2024. Seventy seven ASA III pediatric patients treated with PBT were recruited. Results: The mean age was 4.8 years [standard deviation (SD): 2.1] and 52% were women. The mean duration of the PBT session was 50 min (SD: 17). Extended duration of the PBT session (> 45 min) occurred in 39 patients (51%). Five predictors of extended duration were selected for the final prediction model. In the multivariable model, an age > 45 months showed a near eightfold increased odds of extended duration [Odds ratio (OR): 7.76, 95% confidence interval (95% CI) 1.63–36.99, P = 0.010]. The OR (95% CI) for long-term venous access, no recurrent tumors, hydrocephalus, and craniospinal location were 5.91 (1.47 to 23.79), 3.81 (0.67 to 21.69), 3.79 (0.90 to 15.97), and 2.59 (0.69 to 9.76), respectively. This five-variable model was used to build a nomogram-based score with an area under the receiver operating characteristic curve of 0.84 (95% CI 0.76–0.93). Conclusions: A simple nomogram based on readily available pretreatment data has potential for planning pediatric PBT standard clinical expert practice.
- 1 August 2023
- Published by Wiley in Pediatric Anesthesia
- Vol. 33 (11) , 946-954
Inhalation anesthesia without any intravenous management for pediatric proton beam therapy
Introduction: Proton beam therapy is an oncological treatment, argued to be an appropriate tumor irradiation technique for childhood solid tumors. Due to its duration and the need for immobility, many children require anesthesia for proton therapy sessions. As not many centers in the world provide this therapy, there is little published research about pediatric anesthesia for these cases, and the available data suggest a preference for intravenous anesthesia or combined intravenous and inhalation anesthesia. We conducted this study with the aim of describing and analyzing the inhalation anesthetic management of children undergoing proton therapy at our medical center, comparing our results with studies that have followed different anesthetic protocols.Methods: We reviewed two major databases (Web of Science and Scopus) to find papers that had addressed, to date, anesthesia for pediatric proton therapy. To describe our anesthetic management, we included all pediatric patients treated with proton therapy under anesthesia in our center between June 2020 and August 2021. The characteristics of the patients, their diagnoses, treatments, airway management, drugs administered, duration of induction, and recovery from anesthesia, and adverse effects where all recorded. All anesthesiologists followed a strict anesthetic protocol based only on inhalational anesthesia with sevoflurane delivered via laryngeal mask airway.Results: Of the total of 1082 papers found in Web of Science and Scopus on pediatric proton therapy, 11 have addressed its anesthetic management, using intravenous or combined intravenous and inhalation anesthesia. Between June 2020 and August 2021, 31 children were anesthetized in our center to receive proton therapy under inhalational anesthesia (total number of sessions: 873). The mean anesthesia induction time was 4.1 min (SD = 0.7, 95% CI [3.9, 4.4]). The mean anesthesia recovery time was 13.8 min (SD = 4.1, 95% CI [12.3, 15.3]). The percentage of non‐serious adverse effects was 0.7% (Clopper–Pearson 95% CI [0.3, 1.5]). The percentage of serious adverse effects was 0.1% (Clopper–Pearson 95% CI [0, 0.6]), without statistically significant difference with other published works with different anesthetic approaches.Conclusion: Inhalation anesthesia without any intravenous management for pediatric proton therapy is, in our experience, an effective technique with a complication rate similar to other anesthetic approaches.
- 1 August 2023
- Published by Wiley in Pediatric Anesthesia
- Vol. 33 (11) , 946-954
Inhalation anesthesia without any intravenous management for pediatric proton beam therapy
Introduction: Proton beam therapy is an oncological treatment, argued to be an appropriate tumor irradiation technique for childhood solid tumors. Due to its duration and the need for immobility, many children require anesthesia for proton therapy sessions. As not many centers in the world provide this therapy, there is little published research about pediatric anesthesia for these cases, and the available data suggest a preference for intravenous anesthesia or combined intravenous and inhalation anesthesia. We conducted this study with the aim of describing and analyzing the inhalation anesthetic management of children undergoing proton therapy at our medical center, comparing our results with studies that have followed different anesthetic protocols.Methods: We reviewed two major databases (Web of Science and Scopus) to find papers that had addressed, to date, anesthesia for pediatric proton therapy. To describe our anesthetic management, we included all pediatric patients treated with proton therapy under anesthesia in our center between June 2020 and August 2021. The characteristics of the patients, their diagnoses, treatments, airway management, drugs administered, duration of induction, and recovery from anesthesia, and adverse effects where all recorded. All anesthesiologists followed a strict anesthetic protocol based only on inhalational anesthesia with sevoflurane delivered via laryngeal mask airway.Results: Of the total of 1082 papers found in Web of Science and Scopus on pediatric proton therapy, 11 have addressed its anesthetic management, using intravenous or combined intravenous and inhalation anesthesia. Between June 2020 and August 2021, 31 children were anesthetized in our center to receive proton therapy under inhalational anesthesia (total number of sessions: 873). The mean anesthesia induction time was 4.1 min (SD = 0.7, 95% CI [3.9, 4.4]). The mean anesthesia recovery time was 13.8 min (SD = 4.1, 95% CI [12.3, 15.3]). The percentage of non‐serious adverse effects was 0.7% (Clopper–Pearson 95% CI [0.3, 1.5]). The percentage of serious adverse effects was 0.1% (Clopper–Pearson 95% CI [0, 0.6]), without statistically significant difference with other published works with different anesthetic approaches.Conclusion: Inhalation anesthesia without any intravenous management for pediatric proton therapy is, in our experience, an effective technique with a complication rate similar to other anesthetic approaches.
- 1 March 2023
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 89 (3) , 227-229
Management of a patient with pyruvate dehydrogenase deficiency
Article: Management of a patient with pyruvate dehydrogenase deficiency - Minerva Anestesiologica 2023 March;89(3):227-9 - Minerva Medica - Journals
- 1 March 2023
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 89 (3) , 227-229
Management of a patient with pyruvate dehydrogenase deficiency
Article: Management of a patient with pyruvate dehydrogenase deficiency - Minerva Anestesiologica 2023 March;89(3):227-9 - Minerva Medica - Journals
- Open Access
- 30 July 2022
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 73 (5) , 539-547
Preoperative airway ultrasound assessment in the sniffing position: a prospective observational study
- 30 July 2022
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 73 (5) , 539-547
Open AccessPreoperative airway ultrasound assessment in the sniffing position: a prospective observational study
- 1 December 2017
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 125 (6) , 2169-2170
In Response
- 1 December 2017
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 125 (6) , 2169-2170
In Response
- 1 June 2017
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 124 (6) , 1886-1896
Analysis of Production, Impact, and Scientific Collaboration on Difficult Airway Through the Web of Science and Scopus (1981–2013)
BACKGROUND: Bibliometrics, the statistical analysis of written publications, is an increasingly popular approach to the assessment of scientific activity. Bibliometrics allows researchers to assess the impact of a field, or research area, and has been used to make decisions regarding research funding. Through bibliometric analysis, we hypothesized that a bibliometric analysis of difficult airway research would demonstrate a growth in authors and articles over time.METHODS: Using the Web of Science (WoS) and Scopus databases, we conducted a search of published manuscripts on the difficult airway from January 1981 to December 2013. After removal of duplicates, we identified 2412 articles. We then analyzed the articles as a group to assess indicators of productivity, collaboration, and impact over this time period.RESULTS: We found an increase in productivity over the study period, with 37 manuscripts published between 1981 and 1990, and 1268 between 2001 and 2010 (P< .001). The difficult airway papers growth rate was bigger than that of anesthesiology research in general, with CAGR (cumulative average growth rate) since 1999 for difficult airway >9% for both WoS and Scopus, and CAGR for anesthesiology as a whole =0.64% in WoS, and =3.30% in Scopus. Furthermore, we found a positive correlation between the number of papers published per author and the number of coauthored manuscripts (P< .001). We also found an increase in the number of coauthored manuscripts, in international cooperation between institutions, and in the number of citations for each manuscript. For any author, we also identified a positive relationship between the number of citations per manuscript and the number of papers published (P< .001).CONCLUSIONS: We found a greater increase over time in the number of difficult airway manuscripts than for anesthesiology research overall. We found that collaboration between authors increases their impact, and that an increase in collaboration increases citation rates. Publishing in English and in certain journals, and collaborating with certain authors and institutions, increases the visibility of manuscripts published on this subject.
- 1 June 2017
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 124 (6) , 1886-1896
Analysis of Production, Impact, and Scientific Collaboration on Difficult Airway Through the Web of Science and Scopus (1981–2013)
BACKGROUND: Bibliometrics, the statistical analysis of written publications, is an increasingly popular approach to the assessment of scientific activity. Bibliometrics allows researchers to assess the impact of a field, or research area, and has been used to make decisions regarding research funding. Through bibliometric analysis, we hypothesized that a bibliometric analysis of difficult airway research would demonstrate a growth in authors and articles over time.METHODS: Using the Web of Science (WoS) and Scopus databases, we conducted a search of published manuscripts on the difficult airway from January 1981 to December 2013. After removal of duplicates, we identified 2412 articles. We then analyzed the articles as a group to assess indicators of productivity, collaboration, and impact over this time period.RESULTS: We found an increase in productivity over the study period, with 37 manuscripts published between 1981 and 1990, and 1268 between 2001 and 2010 (P< .001). The difficult airway papers growth rate was bigger than that of anesthesiology research in general, with CAGR (cumulative average growth rate) since 1999 for difficult airway >9% for both WoS and Scopus, and CAGR for anesthesiology as a whole =0.64% in WoS, and =3.30% in Scopus. Furthermore, we found a positive correlation between the number of papers published per author and the number of coauthored manuscripts (P< .001). We also found an increase in the number of coauthored manuscripts, in international cooperation between institutions, and in the number of citations for each manuscript. For any author, we also identified a positive relationship between the number of citations per manuscript and the number of papers published (P< .001).CONCLUSIONS: We found a greater increase over time in the number of difficult airway manuscripts than for anesthesiology research overall. We found that collaboration between authors increases their impact, and that an increase in collaboration increases citation rates. Publishing in English and in certain journals, and collaborating with certain authors and institutions, increases the visibility of manuscripts published on this subject.